Skip to main content

Cancer Biology

Edited by:
Gerry Melino: University of Rome "Tor Vergata", Italy
Valentina Tassinari: University of Rome "Tor Vergata", Italy

Submission Status: Open   |   Submission Deadline: 31 March 2024

Biology Direct is calling for submissions to our new Collection on Cancer Biology. This Collection supports and amplifies research related to SDG 3, Good Health and Well-Being.

Image credit: Michael / Generated with AI /

About the collection

The identification of genes related to cancer origin and progression has been greatly expanded with the establishment of The Cancer Genome Atlas (TCGA) and of the Pan-Cancer Analysis of Whole Genomes (PCAWG) consortia, which include most tumor types, matching DNA sequencing, and RNA transcripts. As a result, we now have a better grasp of the molecular pathways underlying cancer, its biochemistry, and, therefore, new therapeutic targets.

In this Collection, we aim to showcase scientific papers which describe distinct aspects of the molecular mechanisms involved in cancer development and progression, as well as its liaison with new potential therapeutic interventions. We describe distinct aspects of precision oncology, the ability to stratify patients with distinct prognostic features and therapeutic requirements, as well as its liaison with the current complexity of the underlying molecular mechanisms.

  1. The outcome of Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) remain dismal despite the development of treatment. Targeted therapy is gaining more and more attention in improving prognosis.

    Authors: Qiao Zhou, Jiamin Zhang, Jingsong Zhang, Simin Liang, Duo Cai, Han Xiao, Yu Zhu, Wenqiong Xiang, Fernando Rodrigues-Lima, Jianxiang Chi, Fabien Guidez and Li Wang
    Citation: Biology Direct 2024 19:6
  2. The uc.291 transcript controls keratinocytes differentiation by physical interaction with ACTL6A and subsequent induction of transcription of the genes belonging to the epidermal differentiation complex (EDC)....

    Authors: Mara Mancini, Simone Sergio, Angela Cappello, Timea Farkas, Francesca Bernassola, Claudia Scarponi, Cristina Albanesi, Gerry Melino and Eleonora Candi
    Citation: Biology Direct 2023 18:82
  3. Cancer immunotherapy, alone or in combination with conventional therapies, has revolutionized the landscape of antineoplastic treatments, with dendritic cells (DC) emerging as key orchestrators of anti-tumor i...

    Authors: Peng Liu, Liwei Zhao, Guido Kroemer and Oliver Kepp
    Citation: Biology Direct 2023 18:71

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles and Reviews. 

Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Cancer Biology" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.